Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

NCT00176241 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Head and Neck Cancer

Interventions

DRUG: gemcitabine
DRUG: paclitaxel
RADIATION: radiation

Sponsor

Susanne Arnold

Collaborators

[object Object]